Pierce Brosnan has addressed the criticism of his Irish accent in Paramount+ crime drama MobLand. The James Bond actor stars ...

Tom Hardy's limited series Taboo will be leaving BBC iPlayer in just a matter of days. The period drama was co-created by ...

Tando Composites was pleased to have TandoStone, the leading brand of composite stone, featured in Manufacturers Reserve ...

BambooHR®, the easiest-to-use people platform for managing HR, payroll, and benefits, today announced a major platform update featuring embedded AI, compensation benchmarking, and native apps designed ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. There are plenty of strategies for discovering value stocks, but we have ...

James Hardie Industries plc ("James Hardie" or the "Company"), a leader in providing high performance, low maintenance building products and solutions, and a company inspiring how communities design ...

Jamal Roberts was crowned the season 23 winner of the beloved singing competition that has launched multiple A-list stars ...

James Bond star Pierce Brosnan has given his two-word verdict on working with Tom Hardy in the Paramount+ gangster drama MobLand. Get the ...

Andy’s libido was, of course, vigorously policed. In a Hardy movie equivalent to the ritualized moment in a James Bond picture where 007 asks for his vodka martini “shaken not stirred,” Andy typically ...

No matter what choice the Jazz wind up with on May 12, it will be up to Hardy to get the most out of that player as they look to turn things around. LeBron James will likely return to the Los ...

James Hardie Industries plc (NYSE:JHX), a leading manufacturer in the concrete and brick industry with a market capitalization of $10.2 billion, has submitted its latest report to shareholders.

James Hardie has come under fire for sanctioning the merger deal without putting it to an investor vote, prompting the Australian Securities Exchange to more broadly review shareholder approvals ...